Adam Master, MD
Otology & Neurotology · New Orleans, LANPI 1588956064
Payments from drug & device makers
Across 41 payments — averaging $155.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Med-el Corporation$4K
- Cochlear Americas$921
- Medtronic$456
- Optinose US, Inc.$236
- Innovation Technologies Inc$179
- Johnson & Johnson$135
- plus $386 from 5 others
What the payments were for
- Travel & lodging$3,47155%
- Food & beverage$2,88345%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Med-el Corporation | 19 | $4,051 |
| Cochlear Americas | 9 | $921 |
| Medtronic | 3 | $456 |
| Optinose US, Inc. | 2 | $236 |
| Innovation Technologies Inc | 1 | $179 |
| Johnson & Johnson | 2 | $135 |
| Acclarent, Inc | 1 | $126 |
| Aerin Medical Inc. | 1 | $125 |
| Advanced Bionics, LLC | 1 | $103 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Stryker | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mi1250 SYNCHRONY 2 FLEXsoft$3,331
- BCI 602 Kit$3,331
- ADHEAR Professional Kit$3,331
- Baha$750
- Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$612
- OSIA OSI300 IMPLANT$612
- Irrisept$179
- STEALTHSTATION S8 PLATFORM$170
- PTEYE PARATHYROID DETECTION SYSTEM$166
- Nucleus$138
- Osia$138
- Xhance$137
- MED-EL Maestro Cochlear Implant System$132
- Acclarent Aera$126
- VIVAER STYLUS$125
- RHINAER STYLUS$125
- PROPEL$120
- HIRES ULTRA CI HIFOCUS MS ELECTRODE$103
How this compares
Too few otology & neurotology providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ofloxacin | 56 | $2,144 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 14 | $677 |
| Fluocinolone Acetonide Oil | 18 | $622 |
| Fluticasone Propionate | 16 | $191 |
| Ondansetron OdtOndansetron | 17 | $120 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $51 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in New Orleans
- Neal JacksonNew Orleans$8K
- Gauri MankekarShreveport$5K
- Moises ArriagaBaton Rouge$3K
- Gerard GianoliBaton Rouge$659
- Lawrence GardnerShreveport$472
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.